IT1251743B - Drug comprising 2-iodo:melatonin, 2-bromo:melatonin and progestogen - for use as contraceptive, for controlling menstrual cycle and for treating mammary tumours and ovarian and bladder carcinomas - Google Patents

Drug comprising 2-iodo:melatonin, 2-bromo:melatonin and progestogen - for use as contraceptive, for controlling menstrual cycle and for treating mammary tumours and ovarian and bladder carcinomas

Info

Publication number
IT1251743B
IT1251743B IT2233890A IT2233890A IT1251743B IT 1251743 B IT1251743 B IT 1251743B IT 2233890 A IT2233890 A IT 2233890A IT 2233890 A IT2233890 A IT 2233890A IT 1251743 B IT1251743 B IT 1251743B
Authority
IT
Italy
Prior art keywords
melatonin
contraceptive
iodo
drug
progestogen
Prior art date
Application number
IT2233890A
Other languages
Italian (it)
Other versions
IT9022338A1 (en
IT9022338A0 (en
Inventor
Franco Fraschini
Bojidar Stankov
Aldo Laguzzi
Original Assignee
I F L O S A S Di Giorgio Ed Al
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by I F L O S A S Di Giorgio Ed Al filed Critical I F L O S A S Di Giorgio Ed Al
Publication of IT9022338A0 publication Critical patent/IT9022338A0/en
Priority to IT2233890A priority Critical patent/IT1251743B/en
Priority to AT91830402T priority patent/ATE131058T1/en
Priority to EP91830402A priority patent/EP0483077B1/en
Priority to US07/767,084 priority patent/US5272141A/en
Priority to DK91830402.3T priority patent/DK0483077T3/en
Priority to ES91830402T priority patent/ES2082959T3/en
Priority to DE69132061T priority patent/DE69132061D1/en
Priority to AT94113848T priority patent/ATE190490T1/en
Priority to DE69115221T priority patent/DE69115221T2/en
Priority to EP94113848A priority patent/EP0641565B1/en
Priority to JP3251261A priority patent/JP2849692B2/en
Publication of IT9022338A1 publication Critical patent/IT9022338A1/en
Application granted granted Critical
Publication of IT1251743B publication Critical patent/IT1251743B/en
Priority to GR960400577T priority patent/GR3019175T3/en

Links

Abstract

A new drug for human use, having contraceptive and menstural cycle controlling properties, oncostatic action is mammary tumours and melanomes, and antikinetosic action comprises N-acetyl-2-iodo-5-methoxy-triptamine (I) (2-iodomelatonin) or N-acetyl-2-komotryptamine (II) (2-bromomelatonin) and derivs. thereof in association with a progestagen. Also claimed are methods of synthesis for 2-iodomelatonin and 3-bromomelatonin.
IT2233890A 1990-09-28 1990-12-11 Drug comprising 2-iodo:melatonin, 2-bromo:melatonin and progestogen - for use as contraceptive, for controlling menstrual cycle and for treating mammary tumours and ovarian and bladder carcinomas IT1251743B (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT2233890A IT1251743B (en) 1990-12-11 1990-12-11 Drug comprising 2-iodo:melatonin, 2-bromo:melatonin and progestogen - for use as contraceptive, for controlling menstrual cycle and for treating mammary tumours and ovarian and bladder carcinomas
DE69132061T DE69132061D1 (en) 1990-09-28 1991-09-27 Contraceptive and menstrual cycle-regulating preparation with oncostatic properties
DE69115221T DE69115221T2 (en) 1990-09-28 1991-09-27 Method for the synthesis of a preparation for regulating conception and the menstrual cycle with oncostatic, anti-kinetic, preventive and therapeutic properties for the treatment of breast cancer and melanoma.
US07/767,084 US5272141A (en) 1990-09-28 1991-09-27 Contraceptive and menstrual cycle controlling drug having oncostatic therapeutic properties for treatment of mammary tumors and melanomas, and method therefor
DK91830402.3T DK0483077T3 (en) 1990-09-28 1991-09-27 Process for the Synthesis of a Contraceptive and Menstrual Cycle Controlling Drug with Oncostatic, Antikinetosic, Preventive and Therapeutic Properties for the Treatment of Breast Tumors and Melanomas
ES91830402T ES2082959T3 (en) 1990-09-28 1991-09-27 PROCEDURE TO DEVELOP THE SYNTHESIS OF A CONTRACEPTIVE AND CONTROL DRUG OF THE MENSTRUAL CYCLE THAT HAS ANTICINETOSIC, ONCOSTATIC AND THERAPEUTIC PROPERTIES FOR THE TREATMENT OF BREAST TUMORS AND MELANOMAS.
AT91830402T ATE131058T1 (en) 1990-09-28 1991-09-27 METHOD FOR SYNTHESIS OF A PREPARATION FOR REGULATION OF CONCEPTION AND THE MENSTRUAL CYCLE WITH ONCOSTATIC ANTIKINETOSIC, PREVENTIVE AND THERAPEUTIC PROPERTIES FOR THE TREATMENT OF BREAST CANCER AND MELANOMA.
AT94113848T ATE190490T1 (en) 1990-09-28 1991-09-27 CONTRACEPTIVE AND MENSTRUAL CYCLE REGULATING PREPARATION WITH ONCOSTATIC PROPERTIES
EP91830402A EP0483077B1 (en) 1990-09-28 1991-09-27 A method for carrying out the synthesis of a contraceptive and menstrual cycle controlling drug having oncostatic, antikinetosic, preventive and therapeutic properties for treatment of mammary tumours and melanomas.
EP94113848A EP0641565B1 (en) 1990-09-28 1991-09-27 Contraceptive and menstrual cycle controlling drug having oncostatic properties
JP3251261A JP2849692B2 (en) 1990-09-28 1991-09-30 2-Bromomelatonin, a contraceptive and menstrual cycle regulating agent having antitumor properties, and methods for producing the same
GR960400577T GR3019175T3 (en) 1990-09-28 1996-03-04 A method for carrying out the synthesis of a contraceptive and menstrual cycle controlling drug having oncostatic, antikinetosic, preventive and therapeutic properties for treatment of mammary tumours and melanomas.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2233890A IT1251743B (en) 1990-12-11 1990-12-11 Drug comprising 2-iodo:melatonin, 2-bromo:melatonin and progestogen - for use as contraceptive, for controlling menstrual cycle and for treating mammary tumours and ovarian and bladder carcinomas

Publications (3)

Publication Number Publication Date
IT9022338A0 IT9022338A0 (en) 1990-12-11
IT9022338A1 IT9022338A1 (en) 1992-06-11
IT1251743B true IT1251743B (en) 1995-05-23

Family

ID=11194889

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2233890A IT1251743B (en) 1990-09-28 1990-12-11 Drug comprising 2-iodo:melatonin, 2-bromo:melatonin and progestogen - for use as contraceptive, for controlling menstrual cycle and for treating mammary tumours and ovarian and bladder carcinomas

Country Status (1)

Country Link
IT (1) IT1251743B (en)

Also Published As

Publication number Publication date
IT9022338A1 (en) 1992-06-11
IT9022338A0 (en) 1990-12-11

Similar Documents

Publication Publication Date Title
FUJIMORI et al. Sponge fixation method for treatment of early scars
BG51075A1 (en) Composition and method for effective contraception and breast cancer control
Apfelberg et al. Results of argon laser exposure of capillary hemangiomas of infancy—preliminary report
GR3019175T3 (en) A method for carrying out the synthesis of a contraceptive and menstrual cycle controlling drug having oncostatic, antikinetosic, preventive and therapeutic properties for treatment of mammary tumours and melanomas.
IT1173101B (en) DEVICE FOR GENERATING HEAT IN FABRICS OF THE HUMAN BODY AND HEAT GENERATION PROCEDURE, PARTICULARLY FOR THE TREATMENT OF CANCER
AR008430A1 (en) A GEL COMPOSITION FOR HAIR STYLING
AU678341B2 (en) Method for hyperthermic potentiation of tissue
EP0463152A4 (en) Method of inhibiting angiogenesis of tumors
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
DE69932183D1 (en) APPLICATION OF TARGETED RADIUM 223 FOR PALLIATIVE AND THERAPEUTIC TREATMENT OF BONE CANCER
ES2179096T3 (en) USE OF INTERLEUCINE-12 TO PREVENT REACTION OF THE GRAFT AGAINST THE GUEST.
MY164077A (en) Compositions and uses of et743 for treating cancer
IT1251743B (en) Drug comprising 2-iodo:melatonin, 2-bromo:melatonin and progestogen - for use as contraceptive, for controlling menstrual cycle and for treating mammary tumours and ovarian and bladder carcinomas
GR3033319T3 (en) Products for the application of high initial doses of cetrorelix and preparation of a combined package for use in treating diseases.
EP0350738A3 (en) (s)-emopamil for use in the treatment of migraine
CN1038230C (en) Red light therapeutic apparatus for burn
NZ307601A (en) Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
EP1028745A4 (en) Interferon immunotherapy
EP0370597A3 (en) Apparatus using microwaves for thermotherapy
ES2019713A6 (en) Treatment of malignant tumors with 8-chloroadenosine 3',5'-cyclic phosphate, 8-aminoadenosine 3',5'-cyclic phosphate and preparation thereof.
ES2183977T3 (en) COMBINATION OF TEMOZOLOMIDE AND ALFA-INTERFERON FOR THE TREATMENT OF ADVANCED CANCER.
GB9625193D0 (en) Treatment of highly vascular tumours
DE59009724D1 (en) USE OF 7-OH-1,2-BENZOPYRON FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING MALIGNANT TUMORS IN HUMANS.
MD940239A (en) Method for treatment of precancer diseases and of uterine cervix cancer early forms
ITMI912438A0 (en) DRUG FOR HUMAN USE, WITH CONTRACEPTIC AND MENSTRUAL CYCLE REGULATING ACTION, WITH PREVENTIVE AND THERAPEUTIC ONCOSTATIC ACTION IN BREAST CANCERS AND MELANOMA AND WITH ANTIKINETOTIC ACTION AND METHOD OF SYNTHESIS

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971229